For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Abbott Diabetes Care Inc.

USPTO Granted Patents = 1,360

CIPO Patents = 15

EPO Patents = 155

Trademarks = 53

Forward Citations = 31,171

Loading Chart...

Loading Chart...

380 inventors (with patents filed for the assignee):

Gary Alan Hayter (222 out of 225 patents)

Benjamin J Feldman (215 out of 233 patents)

Adam Heller (194 out of 276 patents)

4. Mark Kent Sloan (153 out of 154 patents)

5. Erwin Satrya Budiman (150 out of 150 patents)

6. Fredric C Colman (104 out of 114 patents)

7. Ephraim Heller (102 out of 126 patents)

8. Kenneth J Doniger (91 out of 98 patents)

9. Udo Hoss (90 out of 120 patents)

10. Marc Barry Taub (89 out of 89 patents)

11. Timothy Christian Dunn (80 out of 91 patents)

12. James L Say (79 out of 121 patents)

13. Mark S Vreeke (75 out of 92 patents)

14. Yi Wang (71 out of 77 patents)

15. Daniel Milfred Bernstein (71 out of 72 patents)

Core Competencies:

Analyte Sensors

Medical Devices

Graphical User Interface

Continuous Glucose Monitoring

Modular Analyte Connectivity

Temperature-Compensated Monitoring

NAD(P)-Dependent Enzymes

Wireless Communication

Data Processing in Medical Systems

Focused Sterilization

Noise Rejection Methods

Real-Time Sensitivity Detection

1,360 patents: Sort by Forward Citations

1. D1107921 - Analyte sensor device (2025-12-30),

2. D1107750 - Display screen or portion thereof with graphical user interface (2025-12-30),

3. D1107045 - Display screen or portion thereof with graphical user interface (2025-12-23),

4. 12502102 - Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation (2025-12-23),

5. 12502101 - Analyte sensor devices, connections, and methods (2025-12-23),

6. D1106247 - Display screen or portion thereof with graphical user interface (2025-12-16),

7. 12495993 - Systems, devices and methods for analyte sensor insertion (2025-12-16),

8. D1104014 - Display screen or portion thereof with animated graphical user interface (2025-12-02),

9. 12482558 - Medical devices and methods (2025-11-25),

10. 12478296 - Systems, devices, and methods related to the individualized calibration and/or manufacturing of medical devices (2025-11-25),

11. D1102460 - Display screen or portion thereof with graphical user interface (2025-11-18),

12. 12471850 - Methods of lag-compensation for analyte measurements, and devices related thereto (2025-11-18),

13. 12471814 - Analyte sensors and methods of use thereof (2025-11-18),

14. D1101793 - Display screen or portion thereof with transitional graphical user interface (2025-11-11),

15. 12465251 - Analyte sensors featuring enhancements for decreasing interferent signal (2025-11-11),

Abbott Diabetes Care Inc. is a global leader in glucose monitoring systems for people living with diabetes. They develop and manufacture a range of innovative products and solutions to help individuals effectively manage their blood glucose levels. Their flagship product, Freestyle Libre, is a revolutionary system that eliminates the need for routine finger pricks by continuously monitoring glucose levels through a small sensor worn on the back of the upper arm. With a commitment to improving the lives of people with diabetes, Abbott Diabetes Care Inc. strives to deliver accurate, reliable, and user-friendly solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

1,360 Patents

#1 in Alameda, CA

#85 in California

#362 in US

#710 in the World

Alameda, CA, United States of America

Abbott Diabetes Care Inc.

Forward Citations = 31,171

380 inventors:

Gary Alan Hayter (222 out of 225 patents)

Benjamin J Feldman (215 out of 233 patents)

Adam Heller (194 out of 276 patents)

4. Mark Kent Sloan (153 out of 154 patents)

5. Erwin Satrya Budiman (150 out of 150 patents)

Please report any incorrect information to support@idiyas.com

Loading…